March 2024, New poster is released by the Fungicide Resistance Action Committee (FRAC), revealing the inclusion of Group 54, Benzoxaboroles, in the…
Tag:
Action
-
-
Biocon PharmaceuticalCompaniesGlobal Market
Biocon Biologics set to reap Biosimilar Insulin Glargine Opportunity in US
by adminby adminSummary : Drugmaker is banking on the ramp-up of interchangeable biosimilar insulin glargine expecting the product to boost the revenue and profit…
-
Active Pharmaceutical Ingredients (API)ibuprofenparacetamol
Hyloris announces FDA Acceptance Of New Drug Application for Maxigesic IV in Post-Operative Pain.
by adminby adminHyloris Pharmaceuticals SA, a speciality biopharma company committed to addressing unmet medical needs through reinventing existing medications, announces that the U.S.…